tiprankstipranks
Checkpoint Therapeutics Inc (CKPT)
NASDAQ:CKPT

Checkpoint Therapeutics (CKPT) Financial Statements

1,751 Followers

Checkpoint Therapeutics Financial Overview

Checkpoint Therapeutics's market cap is currently ―. The company's EPS TTM is $-2.931; its P/E ratio is -0.70; Checkpoint Therapeutics is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Sep 23Jun 23Mar 23Dec 22Sep 22
Income Statement-
Total Revenue$ 31.00K$ 31.00K$ 35.00K$ 74.00K$ 48.00K
Gross Profit$ 31.00K$ 31.00K$ 35.00K$ 74.00K-
EBIT$ -5.72M$ -16.52M$ -10.47M$ -16.64M$ -10.66M
EBITDA$ -5.72M$ -16.52M$ -10.47M$ -16.64M$ -10.66M
Net Income Common Stockholders$ -5.72M$ -16.52M$ -10.47M$ -21.02M$ -10.61M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.77M$ 7.42M$ 4.85M$ 12.07M$ 20.48M
Total Assets$ 2.22M$ 8.34M$ 5.90M$ 13.29M$ 21.62M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -1.77M$ -7.42M$ -4.85M$ -12.07M$ -20.48M
Total Liabilities$ 21.26M$ 27.65M$ 24.47M$ 32.77M$ 22.95M
Stockholders Equity$ -19.04M$ -19.31M$ -18.57M$ -19.48M$ -1.33M
Cash Flow-
Free Cash Flow$ -14.75M$ -11.98M$ -14.03M$ -15.30M$ -11.42M
Operating Cash Flow$ -14.75M$ -11.98M$ -14.03M$ -15.30M$ -11.42M
Investing Cash Flow-----
Financing Cash Flow$ 9.10M$ 14.55M$ 6.81M$ 6.89M$ 1.01M
Currency in USD

Checkpoint Therapeutics Earnings and Revenue History

Checkpoint Therapeutics Debt to Assets

Checkpoint Therapeutics Cash Flow

Checkpoint Therapeutics Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis